Siemens Healthineers Expands Brain Health Research Portfolio with New Blood-Based Tau Assays
Siemens Healthineers has announced the availability of two new blood-based biomarker assays for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays. The launch marks an expansion of the company’s brain health research portfolio, with the tests designed to help scientists better understand neurological function and disease … Read more